What NeOnc Technologies Holdings Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 14 | 30 |
| Sells | 1 | 1 |
| Total trades | 15 | 34 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 212,330 | 476,744 |
| Disposed | 0 | 0 |
| Net activity | +212,330 | +476,744 |
Common stock only — 2 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Heshmatpour Amir F | CEO, President | Sep 15 | Open-market buy · P | +35,000 | $3.30 | +$115K | 3,183,000 |
| Garnett Keithly | CFO | Sep 15 | Open-market sale · S | +5,000 | $3.36 | +$16.8K | 237,357 |
| Heshmatpour Amir F | CEO, President | Sep 14 | Open-market buy · P | +15,000 | $3.96 | +$59.4K | 3,148,000 |
| Garnett Keithly | CFO | Sep 14 | Open-market buy · P | +257 | $3.89 | +$1K | 242,357 |
| Chen Thomas C | CEO | Sep 14 | Open-market buy · P | +5,242 | $3.82 | +$20K | 24,503 |
| Heshmatpour Amir F | CEO, President | Sep 11 | Open-market buy · P | +37,000 | $3.67 | +$136K | 3,133,000 |
| Chen Thomas C | CEO | Sep 11 | Open-market buy · P | +5,556 | $3.60 | +$20K | 19,261 |
| Heshmatpour Amir F | CEO, President | Aug 18 | Open-market buy · P | +9,000 | $5.54 | +$49.9K | 3,096,000 |
| Chen Thomas C | CEO | Aug 18 | Open-market buy · P | +12,757 | $5.49 | +$70K | 13,705 |
| Heshmatpour Amir F | CEO, President | Aug 17 | Open-market buy · P | +3,000 | $4.37 | +$13.1K | 3,087,000 |
| Chen Thomas C | CEO | Aug 17 | Open-market buy · P | +2,472 | $4.04 | +$10K | 583,531 |
| Chen Thomas C | Chief Scientific Officer | Aug 17 | Open-market buy · P | +2,472 | $4.04 | +$10K | 583,531 |
| Heshmatpour Amir F | CEO, President | Aug 14 | Open-market buy · P | +12,000 | $3.79 | +$45.5K | 3,084,000 |
| Chen Thomas C | CEO | Aug 14 | Open-market buy · P | +33,787 | $3.85 | +$130K | 581,059 |
| Chen Thomas C | Chief Scientific Officer | Aug 14 | Open-market buy · P | +33,787 | $3.85 | +$130K | 581,059 |
| Shomali Nasim | Director | Jul 10 | Grant / award · A | +50,000 | — | — | 50,160 |
| Heshmatpour Amir F | President | May 01 | Open-market buy · P | +10,000 | $4.16 | +$41.6K | 3,072,000 |
| Heshmatpour Amir F | President | Apr 28 | Open-market buy · P | +10,000 | $4.52 | +$45.2K | 3,062,000 |
| Chen Thomas C | Chief Scientific Officer | Apr 24 | Open-market buy · P | +10,000 | $4.80 | +$48K | 10,000 |
| Neman-Ebrahim Yousha | Chief Clinical Officer | Apr 23 | Open-market buy · P | +500 | $4.88 | +$2.44K | 134,760 |
Loading...
